logo
How Agent Orange, used by the US during war, haunts Vietnam's present

How Agent Orange, used by the US during war, haunts Vietnam's present

Indian Express30-04-2025

April 30 marks the 50th anniversary of the end of the Vietnam War. On that day in 1975, North Vietnamese and Viet Cong troops entered what was then called Saigon and declared victory.
However, even after all these years, millions of Vietnamese people continue to feel the lingering effects of Agent Orange, a toxic chemical that the United States used during the war.
Estimates suggest that currently, there are 3 million people, including many children, in Vietnam who are still suffering from serious health issues associated with exposure to Agent Orange.
What was Agent Orange?
Agent Orange was a blend of herbicides that US forces sprayed over Vietnam to defoliate trees and shrubs, and kill food crops that provided cover and food to North Vietnamese and Viet Cong troops. The chemical comprised a 50-50 mixture of two herbicides — 2,4-D and 2,4,5-T — and a toxic contaminant, known as dioxin.
Although Agent Orange remained toxic for only days or weeks and then degraded, dioxin could survive up to three years in soil that was exposed to sunlight. If buried or leached under the surface or deep in the sediment of rivers and other water bodies, it could have a half-life (time required for any substance to decrease by half) of more than 100 years — more than enough time to be consumed by fish, ducks, and other animals that people eat. People could also be exposed to dioxin through inhaling contaminated dust, and absorbing it through skin. Dioxin has a half-life of up to 20 years in the human body.
How many people were exposed to Agent Orange in Vietnam?
Between 1961 and 1971, the US sprayed around 74 million litres of chemicals over South Vietnam, and border areas of Laos and Cambodia. More than half of this was Agent Orange.
Flying a bare 100 feet above the jungle hills west of Hue, 5 bulky 'C-123 providers' cut loose a spray of chemical defoliant on August 14, 1968. (Photo: AP)
The concentrations were some 20 times the concentration the manufacturers recommended for killing plants, according to a report by The Aspen Institute, a US-based non-profit organisation.
During these years, some 4.8 million Vietnamese people and nearly 2.8 million US soldiers were exposed to Agent Orange. Out of these, three million Vietnamese suffered illnesses because of the chemical, one estimate by Vietnam said.
The US stopped using the chemical in 1971 amid mounting international condemnation and safety concerns. This happened as by the late 1960s, several studies had shown that dioxin could cause abnormalities and stillbirths in mice, and reports of human birth defects in sprayed areas of Vietnam had started to emerge.
However, relatively high concentrations of dioxin continued to linger in some of Vietnam's soils and aquatic sediments, especially near former US air bases that had handled vast volumes of the chemicals, in the years after the war ended.
How is Vietnam still suffering from the impact of Agent Orange?
The severe impact of Agent Orange has been suffered by not only those who were exposed to it during the war, but also the future generations. Over the years, Vietnam has asserted that 'those harmed by Agent Orange included the second-, third-, and even fourth-generation relatives of those who experienced the spraying, because of dioxin lingering in the environment or inherited health effects,' according to a report in the journal Science.
Apart from cancer and diabetes, one of the most prominent health issues among Vietnamese people has been birth defects such as spina bifida (when a baby's spine and spinal cord do not develop properly), oral clefts, cardiovascular defects, hip dislocations and hypospadias (where the opening of the urethra is not at the tip of the penis). In the early 2000s, the Red Cross of Vietnam estimated that at least 150,000 Vietnamese children were born with serious birth defects.
However, there have been only a handful of studies that have shed light on the link between birth defects and exposure to Agent Orange. That is because the US until the mid-2000s largely ignored the impact of the toxin in Vietnam, despite the fact that in 1991, the former accepted that certain diseases could be related to exposure to Agent Orange and made US veterans who had them eligible for benefits.
David Carpenter, a public health physician at the University at Albany (New York), told the journal Science that one reason for the lack of US support in Vietnam was that the issue 'is extremely political' in both countries. He said that if studies had proved a link between birth defects and exposure to dioxin, the US might have been 'expected to pay reparations to Vietnamese children.' Alternatively, if they had found no link, that might have 'embarrassed' the Vietnamese government.
The use of Agent Orange also caused wide-scale damage to the environment in Vietnam. A 1983 report, also published by the journal Science, revealed that many sprayed upland forests that villagers tried to convert to agriculture were 'unsuitable for growing crops and the land has become covered with a coarse, deep-rooting grass.'
Notably, since then there have not been many studies on how forests and wildlife have recovered from the spraying of Agent Orange.
What happens next?
In 2006, the US finally got together with Vietnam and began to clean up Agent Orange from the environment. But as the process of clean up is long and very expensive, there are large sites in Vietnam where the work is far from over. For instance, in Da Nang, where an air base was contaminated during storage and transportation of Agent Orange, an area the size of 10 soccer fields remains heavily contaminated, according to a report by the Associated Press.
Moreover, after the return of President Donald Trump to the White House, major clean-up projects in Vietnam have been halted due to cuts in the United States Agency For International Development (USAID).
Nguyen Van An, the chairman of the Association for Victims of Agent Orange in Danang, told the AP that Vietnam could not handle the toxic chemicals that still persist without help. 'We always believe that the US government and the manufacturers of this toxic chemical must have the responsibility to support the victims,' he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109
Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109

Indian Express

time40 minutes ago

  • Indian Express

Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109

With 131 new cases of Covid in Ahmedabad — the highest single-day rise in the city — the state recorded 235 new cases on Monday. Ahmedabad Municipal Corporation's (AMC's) health officials confirmed that Monday's was the highest number of Covid cases that the city has reported in 24 hours after the fresh spate of cases. The total number of active cases in the state stands at 1,109, including 33 people who needed hospitalisation. Others are undergoing OPD-based treatment. Another 106 people, who recovered from the virus, were discharged on Monday. As per a health bulletin released by the state government, no death was reported in Gujarat on Monday. In Ahmedabad, the tally of cases has gone up to 916, including 646 active. Ahmedabad city has reported two deaths due to Covid. Among the active cases in Ahmedabad, highest were reported in the the west zone at 211, followed by the north west zone at 204, and south west zone at 114. The remaining zones have reported 50 (south zone), 25 (north zone), 24 (east zone), 18 (central zone) cases. According to the Indian SARS-CoV-2 Genomics Consortium (INSACOG), the XFG variant of the Covid-19 has been recently found in a total of 163 samples — with the highest (89) in Maharashtra, followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh and West Bengal (6 each). The recombinant XFG variant harbours four key spike mutations and has achieved rapid global spread following its initial detection in Canada, according to an article in The Lancet journal. In May, as many as 159 samples were detected with XFG variant, two in April, and two in June yet, data shows. India's active Covid case tally crossed the 6,000 mark, with 769 having been added to it in 48 hours, according to Union Health Ministry data released on Sunday

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Time of India

time2 hours ago

  • Time of India

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Cosmetics maker L'Oreal agreed to acquire a majority stake in British skincare brand Medik8, in a strategic move to strengthen its presence in the booming skincare market. The French beauty giant announced the deal on Monday, though financial terms were not disclosed. The transaction, which sees UK-based private equity firm Inflexion selling its majority holding, reportedly values Medik8 at around 1 billion Euro, according to a source familiar with the matter. Inflexion will retain a minority share, while L'Oreal has secured the option to eventually buy out all remaining shareholders, Reuters reported. 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' Cyril Chaupuy, president of L'oreal Luxe said. 'This acquisition further strengthens L'Oreal's luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth,' the company said in a statement. L'Oreal will begin consolidating Medik8's sales once the transaction officially closes. The acquisition is expected to be finalised in the coming months, pending regulatory approvals and standard closing conditions. Simon Coble, CEO of Medik8 also expressed excitement on the brand's behalf. 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' Founded in the UK, Medik8 has built a loyal customer base with its vitamin A-focused anti-ageing creams and serums. The brand is seen as a natural fit for L'Oreal's luxury division, which includes skincare and fragrance names such as Lancome, Aesop, and Miu Miu. Last year, sales in L'Oreal's luxe segment grew by just 2.7%, its weakest performance across divisions, as inflation pushed consumers toward more affordable alternatives. However, the unit scrored better than rival LVMH's beauty arm. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

L'Oreal buys British skincare brand Medik8
L'Oreal buys British skincare brand Medik8

Time of India

time3 hours ago

  • Time of India

L'Oreal buys British skincare brand Medik8

HighlightsL'Oreal is set to acquire the British skincare brand Medik8, enhancing its portfolio in the rapidly expanding dermatological skincare market. Medik8 specializes in vitamin A-based anti-aging creams and serums, and L'Oreal aims to strengthen its presence in existing markets while expanding globally. L'Oreal's dermatological beauty division has been its fastest-growing sector, achieving revenues of 7 billion euros in the previous year, driven by increasing consumer interest in science-backed skincare products. L'Oreal is to acquire British skincare brand Medik8 , its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatological skincare market . The size of the deal was not disclosed. Medik8 focuses on vitamin A-based anti-ageing creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe , La Roche-Posay , and SkinCeuticals , has been its fastest growing in recent years, reaching revenues of 7 billion euros ($7.99 billion) last year, after growing almost 10% on the year before. The business, which also has the highest profit margin among its four divisions, has boomed on growing consumer interest in science-backed products, though growth has slowed recently due to rising competition. L'Oreal executives said this year they were pursuing acquisitions and looking to revive flagging growth. The company acquired Korean skincare brand, Dr.G, in December and also bought a minority stake in Oman-based perfume house Amourage last year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store